Shares of Applied Biosystems Group ( ABI) were climbing higher Wednesday, after the life sciences technology company posted fiscal first-quarter results that showed a loss from a one-time charge.

For the first quarter of fiscal 2007, Applied Biosystems posted a net loss of $58.7 million, or 32 cents a share, compared to net income of $43.1 million, or 21 cents a share, in the prior-year quarter. The Foster City, Calif., company chalked up the loss to a non-recurring charge of $114.3 million, or 63 cents a share, related to its acquisition of Agencourt Personal Genomics.

Excluding the items, earnings per share were 29 cents, up from the 23 cents it reported in the prior-year quarter. Analysts, on average, were expecting earnings of 25 cents a share, according to Thomson First Call.

Applied Biosystems reported revenue of $476.3 million for the first quarter of fiscal 2007, up from the prior-year quarter revenue of $415.5 million. The most recent revenue number included a 4% favorable impact related to its acquisition of the research products division of Ambion. Analysts were looking for $450.2 million in revenue.

Applied Biosystems is a unit of Applera Corp., along with Celera Genomics ( CRA), a diagnostics maker.

Shares of Applied Biosystems were up $4.44, or 13.3%, at $37.95 in recent trading Wednesday.

More from Stocks

Micron Shares Tumble on Mixed Earnings Results

Micron Shares Tumble on Mixed Earnings Results

Amazon and Oracle's Beef Is Carrying Over to the Courtroom in JEDI Dispute

Amazon and Oracle's Beef Is Carrying Over to the Courtroom in JEDI Dispute

U.S. Stocks Bounce Ahead of Fed Rate Hike Comments -- One Key Trend to Remember

U.S. Stocks Bounce Ahead of Fed Rate Hike Comments -- One Key Trend to Remember

In This Stock Market, It's Not Easy Being Green

In This Stock Market, It's Not Easy Being Green

Dow Closes Positive as Stocks Buffeted by Volatile Tuesday Trading

Dow Closes Positive as Stocks Buffeted by Volatile Tuesday Trading